Pharmacokinetics in drug screening.
Grosset
J H
JH
Department of Bacteriology and Virology, Faculty of Medicine Pitie-Salpetriere, Paris, France.
D000818:Animals; D001682:Biological Availability; D001835:Body Weight; D003622:Dapsone / Q000493:pharmacokinetics; D004353:Drug Evaluation, Preclinical; D006801:Humans; D007917:Leprostatic Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use; D007918:Leprosy / Q000188:drug therapy*; D015242:Ofloxacin; D010078:Oxazines / Q000493:pharmacokinetics; D012293:Rifampin / Q000493:pharmacokinetics; D013045:Species Specificity
D007917:Leprostatic Agents; D010078:Oxazines; D003622:Dapsone; D015242:Ofloxacin; D012293:Rifampin